PUBLISHER: Polaris Market Research | PRODUCT CODE: 1423986
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1423986
The global radiation dose management market size is expected to reach USD 1,084.39 Million by 2032, according to a new study by Polaris Market Research. The report "Radiation Dose Management Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Radiation Dose Management Solutions, Radiation Dose Management Services); By Modality; By Mode of Deployment; By End-User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growth of radiation dose management is mainly driven by a rise in the use of medical imaging modalities driven by a surging incidence of chronic diseases. The demand for healthcare services is increasing, which leads to more diagnostic and interventional procedures that use ionizing radiation, like X-rays and CT scans. Both healthcare practitioners and patients are becoming more aware of the importance of managing radiation doses effectively. This emphasizes the need for comprehensive solutions. The combination of these factors, such as the widespread use of medical imaging, the increased awareness of radiation-related risks, the rise in chronic diseases, and the expansion of radiology equipment installations, contribute to the growth of the radiation dose management market.
Radiation dose management is a medical framework designed to control, enhance, or mitigate radiation doses. This is achieved through the use of advanced computed tomography (CT) reduction technologies and barriers. The framework includes tools to monitor patient exposure, optimize processes, ensure quality, manage radiation doses, and implement real-time monitoring of staff doses.
The Radiation Dose Management market is growing owing to technology advancements in radiation therapy, particularly with robot-assisted brachytherapy. The use of advanced technology can enhance radiation therapy for prostate cancer by incorporating high-quality imaging and improving needle placement and seed delivery. This has the potential to raise the standard of care for patients.
Artificial intelligence technologies are increasingly being used in radiology practices, which can have a significant impact on radiation dose management. AI algorithms help to optimize imaging protocols, forecast patient-specific radiation doses, and improve image reconstruction techniques. AI helps to improve risk prediction for cardiovascular disease, lung cancer, and other potential causes of death by using data from low-dose CT scans of the lungs.
The radiation dose management segment dominated the market in 2023, owing to the increasing prevalence of chronic diseases, heightened awareness of radiation-related risks, and elevated accessibility to imaging technologies.
Hospital and healthcare systems dominated the market in 2023 due to the surging acceptance of teleconsultation and telehealth in the healthcare community. Hospitals are the favored healthcare settings for diagnosis and therapy.
North America accounted for the largest market share due to technological advancements, high awareness related to radiation exposure, and advanced healthcare infrastructure.
The Asia Pacific region accounted for the fastest growth, owing to the presence of sturdy healthcare systems in the region.
The global key market players include Agfa-Gevaert Group, Bayer AG, FUJIFILM Holdings Corporation, General Electric Company, Guerbet, Koninklijke Philips N.V., Medic Vision, Novarad, Siemens Healthcare GmbH, and Sectra AB.
Polaris Market Research has segmented the Radiation Dose Management market report based on product & services, modality, mode of deployment, end-user, and region: